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SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comstenting” is feasible for predicting the effect of PCI. However, the validity of FFRct
along the length of a vessel compared with FFRcath is unknown. The purpose of this
study is to compare trans-lesional FFRcath vs. FFRct gradients in vessels with serial
stenoses.
Methods: 18 patients with stable coronary artery disease had pull-back FFRcath
measurements across the serial lesions. In each patient FFRct was performed utilizing
pre-cath cCTA data. Blinded comparisons of FFRcath and FFRct at co-registered
points were performed. Computational models were then modiﬁed to simulate virtual
stenting strategy of the proximal, distal or both lesions.
Results: 18 vessels were assessed, with ischemia (FFRcath 0.80) present in 13
(72.2%). Each patient had 2 or more angiographic stenoses >30% with trans-lesional
FFRcath gradient of 0.100.09. The correlation between FFRcath and FFRct gradient
was r¼0.92, p< 0.001. Virtual stenting demonstrated a wide range of scenarios with
the need for one or two stents for relief of the ischemia. Figure 1 exempliﬁes a case in
which stenting of each single lesion did not result in FFRct >0.8. Virtual stenting of
both stenoses relieved the ischemia with ﬁnal FFRct ¼ 0.84.
Conclusions: Trans-lesional FFRct gradient correlates closely with FFRcath
gradient in vessels with serial stenoses. This is a core foundation for the potential
usefulness of computational modeling to evaluate and plan treatment of complex
and serial stenoses.TCT-319
Instantaneous wave-free ratio (iFR) and fractional ﬂow reserve (FFR) are equally
able to identify ischaemia and ﬂow limitation: a pooled analysis of studies against
SPECT, HSR, CFR and PET
Ricardo Petraco1, Sukhjinder S. Nijjer2, Sayan Sen3, Guus A. de Waard4,
Tim P. van de Hoef5, Mauro Echavarria-Pinto6, Rasha Al-Lamee7,
Martijn A. van Lavieren8, Paul Knaapen9, Javier Escaned10, Jan Piek11,
Niels van Royen9, Justin E. Davies3
1Imperial College, London, United Kingdom, 2Imperial College London, London,
London, 3Imperial College London, London, United Kingdom, 4VU University
Medical Center, AMSTERDAM, Netherlands, 5Academic Medical Center - University
of Amsterdam, Amsterdam, Noord Holland, 6Hospital Universitario Clinico San
Carlos, Madrid, Spain, 7IMPERIAL COLLEGE NHS TRUST, LONDON, LONDON,
8Academic Medical Center, Amsterdam, Noord Holland, 9VU University Medical
Center, Amsterdam, Netherlands, 10Hospital Clinico San Carlos, Madrid, Spain,
11Academic Medical Center, Amsterdam, Netherlands
Background: The instant wave-free ratio (iFR) and fractional ﬂow reserve (FFR) are
indices of coronary disease severity which use pressure as a measure of lesion sig-
niﬁcance. The aim of this study was to quantify iFR and FFR’s individual ability to
detect ischaemia and ﬂow limitation against multiple perfusion modalities.
Methods: Pooled analysis of data using a random effect model. 4 studies which
compared iFR and FFR against the following perfusion modalities were included:
SPECT scintigraphy, positron emission tomography (H215O PET), hyperaemic ste-
nosis resistance (HSR) and coronary ﬂow reserve (CFR). In total, 265 stenoses in 220
patients were evaluated. The performance of iFR and FFR to detect ischaemia or ﬂow
limitation was compared using the area under the ROC curve (AUCROC).B92 JACC Vol 64/11/Suppl B j SeptemberResults: Baseline iFR and hyperaemic FFR demonstrated equal overall agreement
with methods of perfusion (iFR AUCROC¼0.88, FFR AUCROC¼0.88) (Figure).
When non-invasive perfusion methods were used as reference standards, iFR was non-
inferior to FFR (iFR-SPECT AUCROC¼0.84 vs FFR-SPECT AUCROC¼0.88,
p>0.2; iFR-PET AUCROC¼0.85, FFR-PET AUCROC¼0.86, p>0.2). When inva-
sive ﬂow indices were used as reference comparisons, iFR was non-inferior (iFR-HSR
AUCROC¼0.95 vs FFR-HSR AUCROC¼0.97, p>0.3) or superior to FFR (iFR-CFR
AUCROC ¼ 0.82 vs FFR-CFR AUCROC¼0.72, p< 0.01) to detect ﬂow limitation.Conclusions: iFR and FFR are equally able to detect ischaemia and ﬂow limitation,
against multiple perfusion modalities. Studies with hard clinical endpoints will eval-
uate whether the non-inferiority of iFR will translate into favourable clinical
outcomes.
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Background: To compare the clinical outcomes of fractional ﬂow reserve (FFR)
guided percutaneous coronary intervention (PCI) versus coronary artery bypass
grafting (CABG) in left main or triple vessel disease.
Methods: Between January 2008 and December 2011, a total of 1515 patients with
signiﬁcant left main or triple vessel disease received FFR guided PCI (N¼250) or
CABG (N¼1265). Primary endpoint was the composite of death from any cause,
myocardial infarction (MI), stroke, or repeated revascularization (MACCE) at 1 year.
Results: At 1 year follow-up, MACCE occurred 12 (4.8%) in FFR guided PCI group
and 61 (4.8%) in CABG group (P¼0.97). The rate of death were similar between
groups (3 [1.2%] vs. 37 [2.9%], P¼0.12). The rate of the composite of death, MI or
stroke was signiﬁcantly lower in FFF-guided PCI group (3 [1.2%] vs. 51 [4.0%],
P¼0.029). The rate of repeated revascularization was signiﬁcantly lower in CABG
group (9 [3.6%] vs. 13 [1.0%], P¼0.002). After adjustment, the risk of MACCE at 1
year was not signiﬁcantly different between groups (hazard ratio [HR] 0.99, 95%
conﬁdence interval [CI] 0.54-1.85, p¼0.99). The risk of death was not signiﬁcantly
different (HR 0.40, 95% CI 0.14-1.34, P¼0.13). The risk of the composite of death,
MI, or stroke was signiﬁcantly lower in FFR guided PCI group (HR 0.30, 95% CI
0.09-0.96, P¼0.042) and the risk of repeated revascularization was signiﬁcantly lower
in CABG group (HR 3.18, 95% CI 1.35-7.50, P¼0.008).13–17, 2014 j TCT Abstracts/FFR and Physiologic Lesion Assessment
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMConclusions: FFR guided PCI showed the similar clinical outcomes with concurrent
CABG with different safety and efﬁcacy proﬁle. Our results should be conﬁrmed in
the ongoing randomized clinical trial.
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Background: Coronary ﬂow capacity (CFC) is a cross-modality physiological
concept, which integrates both CFR and hyperemic ﬂow to depict the ischemic burden
of the myocardium. Originally derived from positron emission tomography (PET)
imaging, moderate to severe impairment of CFC has been strongly linked to electrical
and clinical manifestations of myocardial ischemia, while no ischemia occurs with
normal or mildly reduced CFC. Analogous to PET-derived CFC, we derived an
invasive CFC concept, and studied the relationship of fractional ﬂow reserve (FFR)
and hyperemic stenosis resistance (HSR) with CFC-deﬁned blood ﬂow impairment.
Methods: Coronary pressure and ﬂow velocity were measured in 299 stenoses. After
stratiﬁcation in normal, mildly reduced, moderately reduced, and severely reduced
CFC using literature-derived CFR cut-offs and the corresponding hyperemic ﬂow
velocity percentiles, FFR and HSR outcomes were evaluated across the four CFC
groups.
Results: Identiﬁcation of severely reduced CFC was excellent for FFR0.80 (90%
agreement) and HSR>0.80 mm Hg/cm/s (92% agreement). However, 40% and 43%
of vessels with normal or mildly reduced CFC had a positive FFR (0.80). Notably,
FFR decreased to 0.77 [0.71-0.81] and 0.49 [0.40-0.64] in the moderately and severely
reduced CFC categories (P< 0.05 compared with all other CFC categories), where
75% of stenoses with severely reduced CFC had FFR< 0.65. HSR increased signif-
icantly with decreasing CFC, and showed less discordance with CFC than FFR (6%
and 11% for normal or mildly reduced CFC). Notably, 13 out of 15 stenoses asso-
ciated with moderately or severely reduced CFC not identiﬁed by FFR0.80, were
characterized by high HMR (3.24 mm Hg/cm/s [2.69 – 3.37 mm Hg/cm/s]), and low
HSR (0.53 mm Hg/cm/s [0.46 – 0.60 mm Hg/cm/s]), suggestive of microcirculatory
disease or low-ﬂow ischemia.
Conclusions: Coronary ﬂow characteristics that determine signs of ischemia are
associated with FFR values far below contemporary interventional thresholds. FFR
seems oversensitive in high-ﬂow settings, and insensitive in low-ﬂow settings. These
ﬁndings corroborate concerns using a pressure-derived estimate of coronary ﬂow
impairment.
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Background: Recently, several parameters (iFR, Pd/Pa and BSR) were proposed to
detect functional signiﬁcance of coronary artery disease (CAD) using baseline coro-
nary pressure, obviating the need for hyperemia. These parameters show a good
correlation with hyperemic fractional ﬂow reserve (FFR). Coronary autoregulation,
i.e. more dilation in case of more severe epicardial stenosiscould be an explanation.
Although some experimental data point in this direction, the hypothesis has never
been tested in humans.
Methods: Simultaneous measurements of coronary pressure and Doppler ﬂow ve-
locity were obtained in 253 vessels in patients with suspected CAD. FFR was used to
indicate functional stenosis severity, while baseline Pd/Pa determined the transstenotic
pressure ratio. Coronary resistance reserve (CRR) was deﬁned as the ratio of hyper-
emic and basal microvascular resistance, indicating the degree of autoregulation.
Baseline average peak velocity (APV) was used as surrogate for coronary ﬂow.
Results: The ﬁgure shows that with increasing stenosis severity (by FFR), baseline
Pd/Pa shows a concomitant progressive decline (P< 0.001 for trend). Also, CRR
decreases with increasing stenosis severity (P< 0.001 for trend) and a stable baseline
APV is maintained (P¼0.25 for trend).
Conclusions: With progressive stenosis severity, baseline coronary ﬂow is preserved
by microvascular resistance reduction (coronary autoregulation), resulting in
decreased perfusion pressure. This explains in part the good performance of resting
pressure measurements to detect signiﬁcant CAD.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/FFTCT-323
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Background: FFR explicitly selected whole-cycle measurements to focus on
epicardial resistance while minimizing capacitive and inductive effects. However,
subsequent work proposed diastolic FFR because coronary ﬂow occurs predominately
during this phase of the cardiac cycle.
Methods: VERIFY enrolled consecutive patients from 5 global sites and used IV
adenosine hyperemia. Each FFR measurement was repeated following a 2 minute rest
period. Whole-cycle and diastolic FFR were computed at a central core lab by
averaging 5 consecutive cycles. Diastole began at the dicrotic notch and ended at the
anacrotic limb.
Results: In 206 patients, test/retest repeatability was excellent for both whole-cycle
and diastolic FFR. An extremely linear relationship existed between the two FFR
metrics, implying that whole-cycle FFR explains 95% of the variation in diastolic
FFR. ROC analysis demonstrated an AUC over 98% for diastolic FFR to predict
FFR0.8.R and Physiologic Lesion Assessment B93
